One of three of  the studies funded by the IRS Outcomes Research Trust Fund Fees ( assessed on health insurers ) will study telehealth vs in-person opioid use disorder (OUD) treatment. The article notes that approximately 9,000 people in the U.S. die every month from drug overdoses even with the availability and easier access of  Buprenorphine. Buprenorphine is a medication which subdues the cravings one has for opioid drugs including heroin and fentanyl. The study will follow patients who leave the emergency room and are referred to an outpatient buprenorphine regimen via in-person clinics or via telehealth providers.  Currently, it has been shown that patients stay compliant with their medication for less than 6 months.  [Since this is the evidence-based answer to the problem of overdoses and deaths, the only thing evident to me is that more questions and answers need to be researched.]